Furthermore, TM4SF5 is also expressed in various other tumor types, such as liver (90%), gastric (75%), and pancreatic (70%) cancers, indicating its potential relevance across a wide range of cancers [18]. This evidence concerns the gene TM4SF5 and neoplasm.